CHA [CHINA TELECOM] 6-K: Page 1.1 Announcement, dated October 25, 2010, regarding
[Page 1.1 Announcement, dated October 25, 2010, regarding the poll results of the extraordinary general meeting held on October 25, 2010. A-1 2]
[Page 1.1 Announcement, dated October 25, 2010, regarding the poll results of the extraordinary general meeting held on October 25, 2010. A-1 2]
[Description 99.1 Announcement on 2010/09/28: To announce related materials on acquisition of machinery and equipment 99.2 Announcement on 2010/09/30: To announce related materials on acquisition of machinery and equipment 99.3 Announcement on 2010/10/07: To announce related materials on acquisition of machinery and equipment 99.4 Announcement on 2010/10/11: To announce related materials on acquisition of machinery and equipment 99.5 Announcement on] [FORM 6-K October 25, 2010 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 10/25/2010 6-K 1 htm_5356.htm LIVE FILING]
[Description 99.1 Announcement on 2010/09/28: To announce related materials on acquisition of machinery and equipment 99.2 Announcement on 2010/09/30: To announce related materials on acquisition of machinery and equipment 99.3 Announcement on 2010/10/07: To announce related materials on acquisition of machinery and equipment 99.4 Announcement on 2010/10/11: To announce related materials on acquisition of machinery and equipment 99.5 Announcement on] [FORM 6-K October 25, 2010 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 10/25/2010 6-K 1 htm_5356.htm LIVE FILING]
[Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:00 pm BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the third quarter ended] [Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:05 pm BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control] [Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R) Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:10 pm BEIJING, Oct 24 /PRNewswire-Asia-FirstCall/ Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today that Sinovac Biotech (Hong Kong) Ltd., its wholly owned subsidiary] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
[Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:00 pm BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the third quarter ended] [Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:05 pm BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control] [Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R) Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:10 pm BEIJING, Oct 24 /PRNewswire-Asia-FirstCall/ Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today that Sinovac Biotech (Hong Kong) Ltd., its wholly owned subsidiary] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
[Amendment No. 4 FORM F-1 AND POST-EFFECTIVE AMENDMENT NO. 1 ON FORM F-1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SGOCO Technology, Ltd. Cayman Islands 3663 N/A (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Classification Code Number) Identification Number) SGOCO Technology Park, Luoshan Jinjiang City, Fujian, China 362200 +86 (595)] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Post-Effective Amendment No. 4 on Form F-1 of our report dated January 22, 2010, relating to the balance sheets of Hambrecht Asia Acquisition Corp. as of June 30, 2009 and December 31, 2008 and 2007, and the related statements of operations and cash flows for the] [Consent of Independent Registered Public Accounting Firm To the Board of Directors SGOCO Technology Ltd. and subsidiaries We consent to the use of our report dated February 12, 2010, with respect to the consolidated balance sheets of SGOCO Technology Ltd. and Subsidiaries (the “Company”) as of December 31, 2009, 2008 and 2007, and the related consolidated statements of income and]